N-[5-({3-[5-(Acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-{5-[(bicyclo[3.3.1]nonane-3-carbonyl)-amino]-pentyl}-N'-hydroxy-succinamide

ID: ALA4204448

Chembl Id: CHEMBL4204448

PubChem CID: 145978722

Max Phase: Preclinical

Molecular Formula: C35H62N6O9

Molecular Weight: 710.91

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)C1CC2CCCC(C2)C1

Standard InChI:  InChI=1S/C35H62N6O9/c1-27(42)39(48)21-8-2-5-18-36-31(43)14-16-33(45)40(49)22-9-3-6-19-37-32(44)15-17-34(46)41(50)23-10-4-7-20-38-35(47)30-25-28-12-11-13-29(24-28)26-30/h28-30,48-50H,2-26H2,1H3,(H,36,43)(H,37,44)(H,38,47)

Standard InChI Key:  AFNPQVXEFPEFRD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4204448

    ---

Associated Targets(Human)

SK-N-BE(2)-M17 (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Astrocyte (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 710.91Molecular Weight (Monoisotopic): 710.4578AlogP: 3.30#Rotatable Bonds: 25
Polar Surface Area: 208.92Molecular Species: NEUTRALHBA: 9HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.92CX Basic pKa: CX LogP: 0.47CX LogD: 0.34
Aromatic Rings: Heavy Atoms: 50QED Weighted: 0.05Np Likeness Score: -0.05

References

1. Telfer TJ, Liddell JR, Duncan C, White AR, Codd R..  (2017)  Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.,  27  (8): [PMID:28285915] [10.1016/j.bmcl.2017.03.001]

Source